Filing Details
- Accession Number:
- 0001773751-23-000129
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-09 18:16:02
- Reporting Period:
- 2023-05-05
- Accepted Time:
- 2023-05-09 18:16:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1837815 | Melissa Baird | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2023-05-05 | 9,133 | $12.04 | 426,412 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2023-05-05 | 9,899 | $12.04 | 416,513 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2023-05-08 | 9,133 | $11.83 | 407,380 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2023-05-08 | 3,833 | $11.83 | 403,547 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2023-05-08 | 19,032 | $0.40 | 422,579 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-05-05 | 19,032 | $0.40 | 19,032 | $0.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
906,632 | 2028-03-28 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.74 - $12.23. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.76 - $12.245. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.69 - $12.03. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.73 - $12.00. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.
- Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.